Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi|January 1, 2013
Severe invasive listeriosis--case reportAndra Teodor, D Teodor, Egidia Miftode, et al.Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi|January 27, 2012
[Epidemiology and clinical features in diabetic patients with invasive infections treated at the Clinical Hospital of Infectious Diseases of Iaşi, Romania, between 2008-2010]Cristina Gabriela Petrovici, Carmen Dorobăt, Codrina Bejan, et al.Frontiers in Immunology|October 8, 2024
Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infectionsTudorita Gabriela Paranga, Mariana Pavel-Tanasa, Daniela Constantinescu, et al.Healthcare (Basel, Switzerland)|July 2, 2021
Diabetes Mellitus-A Risk Factor for Unfavourable Outcome in COVID-19 Patients-The Experience of an Infectious Diseases Regional HospitalEgidia Miftode, Larisa Miftode, Ioana Coman, et al.Biomedical Reports|September 9, 2024
Diagnosis and treatment challenges in a rare Clostridium infection: A case reportBianca Bălaș-Maftei, Carmen-Elena Florea, Maria Obreja, et al.Geriatrics & Gerontology International|November 16, 2017
Clostridium difficile infection in hospitalized octogenarian patientsAnca Trifan, Irina Girleanu, Carol Stanciu, et al.International Journal of Molecular Sciences|November 9, 2024
Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic ApproachesTudorita Gabriela Paranga, Ivona Mitu, Mariana Pavel-Tanasa, et al.Antibiotics (Basel, Switzerland)|February 25, 2023
The Clash of the Titans: COVID-19, Carbapenem-Resistant Enterobacterales, and First mcr-1-Mediated Colistin Resistance in Humans in RomaniaIonela-Larisa Miftode, Daniela Leca, Radu-Stefan Miftode, et al.Antibiotics (Basel, Switzerland)|June 28, 2023
Multidrug-Resistant (MDR) Urinary Tract Infections Associated with Gut Microbiota in CoV and Non-CoV Patients in a Urological Clinic during the Pandemic: A Single Center ExperienceViorel Dragos Radu, Radu Cristian Costache, Pavel Onofrei, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|March 16, 2021
Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST StudyAnca Trifan, Carol Stanciu, Laura Iliescu, et al.Pageof 4